sb 202190 has been researched along with Nociceptive Pain in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Nociceptive Pain: Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavao-de-Souza, GF | 1 |
| Zarpelon, AC | 1 |
| Tedeschi, GC | 1 |
| Mizokami, SS | 1 |
| Sanson, JS | 1 |
| Cunha, TM | 1 |
| Ferreira, SH | 1 |
| Cunha, FQ | 1 |
| Casagrande, R | 1 |
| Verri, WA | 1 |
1 other study available for sb 202190 and Nociceptive Pain
| Article | Year |
|---|---|
Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice.
Topics: Acetic Acid; Androstadienes; Animals; Anthracenes; Benzoquinones; Disease Models, Animal; Flavonoids | 2012 |